Kyle Carver

Insider Reports History

Location
450 East 29 Th Street, New York, NY
Signature
/s/ Gregory S. Moss, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kyle Carver:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Evommune, Inc. Chief Financial Officer Employee Stock Option (Right to Buy) 279K Nov 5, 2025 Direct
Evommune, Inc. Chief Financial Officer Common Stock 75.8K Nov 7, 2025 Direct
Evommune, Inc. Chief Financial Officer Series B Preferred Stock 0 Nov 7, 2025 Direct
Kadmon Holdings, Inc. SVP, CAO, Controller Common Stock 0 $9.50 Nov 9, 2021 Direct
Kadmon Holdings, Inc. SVP, CAO, Controller Stock Option (right to buy) 0 $5.54 Nov 9, 2021 Direct

Insider Reports Filed by Kyle Carver

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EVMN Evommune, Inc. Nov 7, 2025 2 $0 4 Nov 12, 2025 Chief Financial Officer
EVMN Evommune, Inc. Nov 5, 2025 1 $0 4 Nov 7, 2025 Chief Financial Officer
EVMN Evommune, Inc. Nov 5, 2025 0 $0 3 Nov 5, 2025 Chief Financial Officer
KDMN Kadmon Holdings, Inc. Nov 9, 2021 6 -$2.52M 4 Nov 9, 2021 SVP, CAO, Controller